4//SEC Filing
Kalnik Matthew W. 4
Accession 0001455244-10-000095
CIK 0000072444other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 5:42 PM ET
Size
5.2 KB
Accession
0001455244-10-000095
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Sale
Common Stock
2010-04-13$5.78/sh−2,250$13,005→ 47,350.104 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001459477
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 5:42 PM ET
- Size
- 5.2 KB